---
trial_id: 7
discovery_date: 2022-03-09 19:26:18.164220
date: 2022-03-09 19:26:18.164220
title: "A Study to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of Natalizumab (BG00002) Administered Subcutaneously to Japanese Participants With Relapsing-Remitting Multiple Sclerosis"
summary: |
  <b>Condition</b>:    Multiple Sclerosis, Relapsing-Remitting<br /><b>Intervention</b>:    Drug: Natalizumab<br /><b>Sponsor</b>:    Biogen<br /><b>Not yet recruiting</b>
link: 'https://clinicaltrials.gov/ct2/show/NCT05265728?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14'
published_date: 2022-03-03 17:00:00
trial_source: ClinicalTrials.gov
relevant: 
options:
  unlisted: false
---
<b>Condition</b>:    Multiple Sclerosis, Relapsing-Remitting<br /><b>Intervention</b>:    Drug: Natalizumab<br /><b>Sponsor</b>:    Biogen<br /><b>Not yet recruiting</b>